Results 131 to 140 of about 380,673 (266)

Optimization and <i>In Vivo</i> Characterization of a Series of Cbl‑b Inactive-State Inhibitors. [PDF]

ACS Med Chem Lett
Lambrecht MJ, Liang J, Ung PM, Huestis MP, Zhu BY, Barton LM, Castanedo GM, Zbieg JR, Larouche-Gauthier R, Jakalian A, Leclerc JP, Yadav A, Haghshenas P, Aubert-Nicol S, Ismaili H, Zhao L, Leblanc M, Wang J, Wang S, Wang Q, Garner T, Tan S, Prangley M, Broccatelli F, Pang J, Murray J, Yu C, Hsu P, Rutz S, Kakiuchi-Kiyota S, Ishizuka I, Leung DH, Kou P, Bao L, Wang X.   +34 more
europepmc   +1 more source

LM POTENCY / FIFTY- MILLESIMAL OR Q POTENCY

LM potency, also called fifty-millesimal or Q potency, is a significant innovation inhomeopathic medicine attributed to Dr. Samuel Hahnemann in the final phase of his clinicalpractice. LM potencies offer distinctive benefits, including gentleness, adaptability,effectiveness in chronic and deep-seated diseases, and suitability for hypersensitive or ...
openaire   +2 more sources

Safety of Daprodustat for the Treatment of Chronic Kidney Disease Anemia: Final Analysis of a Multicenter Postmarketing Surveillance Study in Japan

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction This final analysis of a multicenter, prospective postmarketing surveillance study evaluated the safety of daprodustat in patients with chronic kidney disease anemia in routine clinical practice in Japan. Methods Patients who initiated daprodustat between September 2020 and July 2022 were registered.
Tadao Akizawa, Kyomi Kanaya, Kiyomi Aizawa, Masanori Onoki, Hirofumi Ozeki, Kazuko Suzuki, Ai Hayashi, Tomohiko Asamura   +7 more
wiley   +1 more source

Establishment and Validation of a Cell-Based Relative Potency Method for Respiratory Syncytial Virus mRNA Vaccine Drug Substance. [PDF]

Vaccines (Basel)
Zheng S, Zhang X, Li W, Zhao H.
europepmc   +1 more source

Concurrent Treatment With Lorlatinib and Dinutuximab Beta Induced Acute Gastric Dilation in a Pediatric Patient With Neuroblastoma

Pediatric Blood &Cancer, EarlyView.
Suna Lin, Linjie Li, JiJun Chen, Zhaokun Tao, Lifeng Zhang, Junqing Mao, Jinhu Wang   +6 more
wiley   +1 more source

Forecasting the Dialysis Burden in Japan: Validation‐Based Projections of Prevalence and Incidence Through 2050

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Japan has one of the highest dialysis prevalence rates worldwide and a shrinking, aging population. Whether dialysis burden has entered a sustained post‐peak phase or whether recent declines partly reflect pandemic‐related disruptions remains uncertain.
Hatice Şahin, Berrak Itır Aylı, Nüket Paksoy   +2 more
wiley   +1 more source

Lipidated peptides and the limits of chemical control. [PDF]

Front Chem
Roque-Borda CA, Sharma A, Pavan FR, de la Torre BG, Albericio F.   +4 more
europepmc   +1 more source

Early‐Phase Research in Pediatric Neuro‐Oncology

Pediatric Blood &Cancer, EarlyView.
Jonathan Cunningham
wiley   +1 more source

Association Between Individualized Education for Kidney Replacement Therapy Modality Selection and Peritoneal Dialysis Initiation: A Cross‐Sectional Study

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction Peritoneal dialysis (PD) is an established home‐based kidney replacement therapy (KRT), but its uptake remains low in Japan. We evaluated whether individualized education in a dedicated outpatient clinic was associated with the initiation of PD.
Yasuko Ito, Ryuichi Yoshimura, Takaki Yamauchi, Yuta Funakoshi, Hirotaka Sonoda, Seiji Kobayashi, Hiroyuki Terawaki, Takafumi Ito   +7 more
wiley   +1 more source

Novel Competitive, Nonpeptidic, SARS-CoV‑2 M^pro Inhibitors with Improved Solubility. [PDF]

ACS Med Chem Lett
Sahin Z, Rivera M, Yang Y, Liu K, Sahin GPC, Bacsa J, Pelly SC, Liotta DC.   +7 more
europepmc   +1 more source